|
|
|
|
Pilot |
 |
A clear trend towards potent and therefore low dosage drugs is a challenge for intermediate and API suppliers. DOTTIKON EXCLUSIVE SYNTHESIS meets this demand with three stand alone, fully qualified pilot/small scale plants. cGMP standard is applied whenever required.
These facilities are used for small scale production on one hand and on the other for process tech. transfer and scale up to feed our large scale, multipurpose plants.
|
|
|
|
|
|
© Copyright 2008, DOTTIKON ES HOLDING AG
|
|
